GB0303289A
GB0303289D0
(en)
|
2003-02-13 |
2003-02-13 |
Combination therapy
|
ES04710081T
ES2364030T3
(en)
|
2003-02-13 |
2004-02-11 |
COMBINATION THERAPY OF ZD6474 WITH 5-FU AND / OR CPT-11.
|
US10/543,106
US20060142316A1
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy
|
EP04710081A
EP1592423B1
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of zd6474 with 5-fu and/or cpt-11
|
CNB200480009817XA
CN100502866C
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy
|
NZ541297A
NZ541297A
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of ZD6474 with 5-FU or/and CPT-11
|
KR1020107027024A
KR20110006699A
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline with 5-flurouracil or/and irinotecan
|
AT04710081T
ATE506062T1
(en)
|
2003-02-13 |
2004-02-11 |
COMBINATION THERAPY OF ZD6474 WITH 5-FU OR/AND CPT-11
|
PT04710081T
PT1592423E
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of zd6474 with 5-fu and/or cpt-11
|
CA2514227A
CA2514227C
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of zd6474 with 5-fu or/and cpt-11
|
SI200431690T
SI1592423T1
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of zd6474 with 5-fu and/or cpt-11
|
DK04710081.3T
DK1592423T3
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of ZD6474 with 5-FU and / or CPT-11
|
KR1020057014913A
KR20050100683A
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of zd6474 with 5-fu or/and cpt-11
|
JP2006502268A
JP2006517575A
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy
|
PCT/GB2004/000550
WO2004071397A2
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of zd6474 with 5-fu or/and cpt-11
|
AU2004212255A
AU2004212255B2
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of ZD6474 with 5-FU or/and CPT-11
|
DE602004032310T
DE602004032310D1
(en)
|
2003-02-13 |
2004-02-11 |
COMBINATION THERAPY OF ZD6474 WITH 5-FU OR / AND CPT-11
|
MXPA05008583A
MXPA05008583A
(en)
|
2003-02-13 |
2004-02-11 |
Combination therapy of zd6474 with 5-fu or/and cpt-11.
|
BR0407301-0A
BRPI0407301A
(en)
|
2003-02-13 |
2004-02-11 |
Use of a combination, pharmaceutical composition, kit, and method for treating cancer in a warm-blooded animal such as a human.
|
IL169702A
IL169702A
(en)
|
2003-02-13 |
2005-07-17 |
Use of zd6474 with 5-fu or/and cpt-11 in the manufacture of medicaments for the treatment of cancer and pharmaceutical compositions and kits comprising the same
|
NO20053649A
NO331486B1
(en)
|
2003-02-13 |
2005-07-27 |
Use of 4- (4-bromo-2-fluoroanilino) -6-methoxy-7- (1-methylpiperidin-4-ylmethoxy) quinazoline also known as ZD6474, or a pharmaceutically acceptable salt thereof and ± n of: a) 5- FU; b) CPT-11; and c) 5-FU and CPT-11, in the manufacture of a medicament for use in the treatment of cancer in a warm-blooded animal such as a human, as well as a pharmaceutical composition and kits containing the same
|
ZA200506211A
ZA200506211B
(en)
|
2003-02-13 |
2005-08-03 |
Combination therapy of ZD6474 with 5-FU or/and CT-11
|
HK06104405.5A
HK1084032A1
(en)
|
2003-02-13 |
2006-04-11 |
Combination therapy of zd6474 with 5-fu and/or cpt-11
|
US12/501,599
US20100130520A1
(en)
|
2003-02-13 |
2009-07-13 |
Combination therapy
|
JP2010238996A
JP5563950B2
(en)
|
2003-02-13 |
2010-10-25 |
Combination therapy
|
US12/973,271
US20110086870A1
(en)
|
2003-02-13 |
2010-12-20 |
Combination Therapy
|
CY20111100565T
CY1111565T1
(en)
|
2003-02-13 |
2011-06-15 |
ZD6474 5-FU AND / OR CPT-11 COMBINATION TREATMENT
|
US13/282,750
US20120252826A1
(en)
|
2003-02-13 |
2011-10-27 |
Combination Therapy
|
JP2014010618A
JP2014065750A
(en)
|
2003-02-13 |
2014-01-23 |
Combination therapy
|